Lonza's competitors

Lonza's competitors include Flex Pharma, Pieris Pharmaceuticals, Hybrigenics and IOmet Pharma
Add company...
Lonza
Lonza is one of the world's leading suppliers to the Pharma&Biotech and Specialty Ingredient markets with products that enhance your overall quality of life.
Flex Pharma
Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms.
Pieris Pharmaceuticals
Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company.
Hybrigenics
Hybrigenics offers a bioinformatics platforms to identify, validate, and inhibit protein interactions to develop therapeutics for cancer.
IOmet Pharma
IOmet Pharma, a UK-based company, discovers and develops novel small molecules for the treatment of cancer. Our pipeline is focused on the exciting fields of cancer immunotherapy and cancer metabolism.
Founding Date
Founding Date
1897
Founding Date
2014
Founding Date
2001
Founding Date
1998
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Basel, CH HQ
Locations
Boston, US HQ
Locations
Boston, US HQ
Locations
Paris, FR HQ
Locations
Edinburgh, GB HQ
Employees
Employees
10,342
Employees
30
Employees
49
Employees
55
Employees
5
Valuation ($)
Valuation ($)
16.4 b
Valuation ($)
74.8 m
Valuation ($)
383.1 m
Valuation ($)
23.8 m
Valuation ($)
N/A
Facebook followers
Facebook followers
31.4 k
Facebook followers
2.1 k
Facebook followers
N/A
Facebook followers
N/A
Facebook followers
N/A
Twitter followers
Twitter followers
4.8 k
Twitter followers
458
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$1m (FY, 2016)
Revenue (est.)
$5.8m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($8m) (FY, 2016)
Net income
($22.8m) (FY, 2016)
Net income
N/A
Net income
(£17.1m) (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles